SHILPA MEDICARE
|
SHILPA MEDICARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 12.44 | 8.01 | 3.67 | -3.74 | 6.99 |
| CEPS(Rs) | 18.56 | 9.78 | 8.05 | 3.72 | 8.09 |
| DPS(Rs) | 0.60 | 1.00 | - | - | 1.10 |
| Book NAV/Share(Rs) | 132.47 | 241.58 | 208.37 | 205.44 | 209.93 |
| Tax Rate(%) | 17.60 | 36.00 | 41.19 | 19.24 | 40.76 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 24.75 | 23.81 | 20.45 | 8.41 | 17.21 |
| EBIT Margin(%) | 23.01 | 15.38 | 12.69 | 1.94 | 12.52 |
| Pre Tax Margin(%) | 19.19 | 9.51 | 4.72 | -3.65 | 8.93 |
| PAT Margin (%) | 15.81 | 6.09 | 2.77 | -2.94 | 5.29 |
| Cash Profit Margin (%) | 23.59 | 14.87 | 12.14 | 6.15 | 12.26 |
| Performance Ratios | |||||
| ROA(%) | 6.97 | 2.45 | 1.07 | -1.07 | 2.20 |
| ROE(%) | 9.82 | 3.75 | 1.78 | -1.71 | 3.67 |
| ROCE(%) | 11.43 | 6.95 | 5.49 | 0.80 | 5.94 |
| Asset Turnover(x) | 0.44 | 0.40 | 0.38 | 0.36 | 0.42 |
| Sales/Fixed Asset(x) | 0.69 | 0.64 | 0.61 | 0.59 | 0.73 |
| Working Capital/Sales(x) | 5.88 | 4.15 | 6.30 | -70.52 | 4.16 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.44 | 1.56 | 1.65 | 1.70 | 1.37 |
| Receivable days | 113.81 | 118.15 | 113.53 | 123.51 | 98.75 |
| Inventory Days | 84.76 | 98.29 | 105.35 | 117.32 | 109.68 |
| Payable days | 101.94 | 128.16 | 146.72 | 126.70 | 106.00 |
| Valuation Parameters | |||||
| PER(x) | 28.03 | 41.41 | 125.64 | - | 56.83 |
| PCE(x) | 18.78 | 33.90 | 28.64 | 30.83 | 24.56 |
| Price/Book(x) | 2.63 | 2.74 | 2.21 | 1.12 | 1.89 |
| Yield(%) | 0.17 | 0.15 | - | - | 0.28 |
| EV/Net Sales(x) | 4.83 | 5.47 | 4.26 | 2.63 | 3.57 |
| EV/Core EBITDA(x) | 16.72 | 20.55 | 19.43 | 23.11 | 18.78 |
| EV/EBIT(x) | 20.99 | 35.59 | 33.59 | 135.78 | 28.55 |
| EV/CE(x) | 2.29 | 2.39 | 1.79 | 1.07 | 1.64 |
| M Cap / Sales | 4.43 | 5.04 | 3.48 | 1.90 | 3.01 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 19.62 | 11.71 | 9.66 | -8.33 | 27.12 |
| Core EBITDA Growth(%) | 29.72 | 35.64 | 111.11 | -45.13 | 2.98 |
| EBIT Growth(%) | 78.96 | 35.39 | 617.36 | -85.80 | -33.88 |
| PAT Growth(%) | 210.81 | 145.00 | 203.36 | -151.03 | -58.56 |
| EPS Growth(%) | 55.40 | 118.00 | 198.15 | -153.54 | -61.45 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.25 | 0.25 | 0.52 | 0.45 | 0.37 |
| Current Ratio(x) | 1.31 | 1.46 | 1.26 | 0.98 | 1.45 |
| Quick Ratio(x) | 0.88 | 0.94 | 0.77 | 0.58 | 0.88 |
| Interest Cover(x) | 6.02 | 2.62 | 1.59 | 0.35 | 3.48 |
| Total Debt/Mcap(x) | 0.10 | 0.09 | 0.23 | 0.40 | 0.20 |
Compare Financial Ratios of peers of SHILPA MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHILPA MEDICARE | ₹15,931.6 Cr | 0.7% | 35% | 81.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
SHILPA MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHILPA MEDICARE | 0.7% |
35% |
81.1% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses
